Resistance can also be acquired to small molecule inhibitors such as the inhibitor of the epidermal growth factor receptor (EGFR) in malignant gliomas and lung cancer [29,30] or androgen receptor inhibitors in prostate cancer [31]. The gene discussed is EGFR; the disease is prostate carcinoma.